Human exposure to the metal lead (Pb) is prevalent and associated with adverse neurodevelopmental and neurodegenerative outcomes. Pb disrupts normal brain function by inducing oxidative stress and neuroinflammation, altering cellular metabolism, and displacing essential metals. Prior studies on the molecular impacts of Pb have examined bulk tissues, which collapse information across all cell types, or in targeted cells, which are limited to cell autonomous effects. These approaches are unable to represent the complete biological implications of Pb exposure because the brain is a cooperative network of highly heterogeneous cells, with cellular diversity and proportions shifting throughout development, by brain region, and with disease. New technologies are necessary to investigate whether Pb and other environmental exposures alter cell composition in the brain and whether they cause molecular changes in a cell-type-specific manner. Cutting-edge, single-cell approaches now enable research resolving cell-type-specific effects from bulk tissues. This article reviews existing Pb neurotoxicology studies with genome-wide molecular signatures and provides a path forward for the field to implement single-cell approaches with practical recommendations.
Keyphrases
- single cell
- heavy metals
- rna seq
- induced apoptosis
- oxidative stress
- genome wide
- white matter
- resting state
- high throughput
- aqueous solution
- cerebral ischemia
- gene expression
- functional connectivity
- cell cycle arrest
- dna methylation
- risk assessment
- endothelial cells
- traumatic brain injury
- health risk assessment
- systematic review
- stem cells
- dna damage
- endoplasmic reticulum stress
- cell proliferation
- randomized controlled trial
- air pollution
- healthcare
- skeletal muscle
- cognitive impairment
- health information
- lps induced
- blood brain barrier
- insulin resistance
- brain injury
- drug induced
- glycemic control